ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1,2,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1,6,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1,7,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
2,1,Blood viscosity increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
2,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
2,3,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
3,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
3,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
4,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
5,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
5,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
6,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
7,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
8,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
8,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
9,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,3,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
10,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
10,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
10,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
11,1,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
11,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
12,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
13,1,Dermatomyositis,Connective tissue disorders,Epidermal and dermal conditions,Skin,N
14,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
14,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
14,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
15,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
15,2,Headache,Headaches NEC,Headaches,Nerv,N
15,3,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
16,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
16,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
16,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
17,1,Folliculitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
18,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
19,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
19,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
19,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
19,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
19,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
19,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
20,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
21,1,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
22,1,Eye inflammation,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
22,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
22,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
23,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
23,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
24,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
25,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
26,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
26,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
26,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
27,1,Sinus node dysfunction,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
28,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
28,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
28,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
28,4,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
29,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
29,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
30,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
31,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
31,3,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
32,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
33,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
33,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
34,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
34,2,Polydactyly,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
35,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
35,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
36,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
37,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
37,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
38,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
38,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
39,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
39,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
40,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
40,2,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
41,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
42,1,Blood glucose abnormal,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
42,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
43,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
43,2,Blood cholesterol increased,Cholesterol analyses,Lipid analyses,Inv,N
43,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
43,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
44,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
45,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
46,1,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
46,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
46,3,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
46,4,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
47,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
48,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
48,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
48,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
48,4,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
48,5,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
48,6,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
48,7,Headache,Headaches NEC,Headaches,Nerv,N
48,8,Hyperglycaemia,Hyperglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
48,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
49,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
50,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
51,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
51,2,Gout,Disorders of purine metabolism,Purine and pyrimidine metabolism disorders,Metab,N
52,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
52,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
52,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
53,1,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
53,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
53,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
53,4,Metal poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
53,5,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
54,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
55,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
55,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
56,1,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
56,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
57,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
57,2,Intervertebral disc disorder,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
57,3,Post procedural complication,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
57,4,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
58,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
59,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
59,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
59,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
60,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
61,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
61,2,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
62,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
63,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
63,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
63,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
64,1,Hepatic fibrosis,Hepatic fibrosis and cirrhosis,Hepatic and hepatobiliary disorders,Hepat,N
64,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
65,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
65,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
66,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
66,2,Mastitis,Breast infections,Infections - pathogen unspecified,Infec,N
67,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
68,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
68,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
68,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
69,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
69,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
69,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
69,4,Headache,Headaches NEC,Headaches,Nerv,N
69,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
69,6,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
69,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
69,8,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
69,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
69,10,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
70,1,Catheter site extravasation,Implant and catheter site reactions,Administration site reactions,Genrl,N
70,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
71,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
72,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
72,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
73,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
73,2,Cor pulmonale acute,Right ventricular failures,Heart failures,Card,N
73,3,Inadequate aseptic technique in manufacturing of product,Manufacturing production issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
74,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
74,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
74,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
74,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
74,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
75,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
75,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
76,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
76,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
76,3,Headache,Headaches NEC,Headaches,Nerv,N
76,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
76,5,Migraine,Migraine headaches,Headaches,Nerv,N
77,1,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
78,1,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
78,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
78,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,1,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
79,2,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
80,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
80,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
80,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
80,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
80,5,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
81,1,Antipsychotic drug level increased,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
82,1,Headache,Headaches NEC,Headaches,Nerv,N
82,2,Migraine,Migraine headaches,Headaches,Nerv,N
83,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
84,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
84,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
84,3,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
84,4,Dysaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
84,5,Excessive dietary supplement intake,Dietary and nutritional therapies,Therapeutic procedures and supportive care NEC,Surg,N
84,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
84,7,Metal poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
84,8,Peripheral sensorimotor neuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
84,9,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
85,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
86,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
86,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
87,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
88,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
88,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
89,1,Infusion site pruritus,Infusion site reactions,Administration site reactions,Genrl,N
89,2,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
90,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
90,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
91,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
91,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
92,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
93,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
94,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
94,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
94,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
95,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
96,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
96,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
96,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
97,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
98,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
98,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
99,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
99,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
99,3,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
100,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
100,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
101,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
101,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
101,4,Cachexia,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
101,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
101,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
101,7,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
101,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
101,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,10,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
101,11,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
101,12,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
101,13,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
102,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
102,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
102,3,Hypervitaminosis,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
102,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
103,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
103,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
103,3,Hypervitaminosis,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
103,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
104,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
104,2,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
104,3,Hypervitaminosis,Hypervitaminoses NEC,Vitamin related disorders,Metab,N
104,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
105,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
106,1,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
107,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
108,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
109,1,Dermatitis contact,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
109,2,Dyshidrotic eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
110,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
111,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
111,2,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
112,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
112,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
113,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
114,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
115,1,Respiration abnormal,Breathing abnormalities,Respiratory disorders NEC,Resp,N
115,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
115,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
116,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
117,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
117,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
117,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
118,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
118,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
119,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
119,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
119,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
119,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
120,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
120,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
120,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
120,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
120,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
121,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
121,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
122,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
123,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
123,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
123,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
123,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
123,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
123,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
124,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
124,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
124,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
125,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
126,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
126,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
126,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
126,4,Keratoneuralgia,Corneal disorders NEC,Eye disorders NEC,Eye,N
127,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
